Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Post-mortem Redistribution of Alprazolam in Rats

J. Hořínková, P. Kozlík, T. Křížek, D. Michaličková, M. Šíma, O. Slanař

. 2020 ; 121 (4) : 244-253.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21003457

Grantová podpora
SVV 260523 Univerzita Karlova v Praze
UNCE/SCI/014 Univerzita Karlova v Praze

The post-mortem toxicological findings may be misinterpreted, if the drug undergoes substantial post-mortem redistribution. As alprazolam is one of the most frequently evaluated drug for legal/forensic reasons in drug-related fatalities, we studied possible changes in alprazolam distribution after death in a rat model. Rats were sacrificed 30 minutes after alprazolam administration. Blood and tissue samples from 8 animals per sampling time were collected at 0, 2, 6, and 24 h after death. The experimental samples were assayed for alprazolam using validated UHPLC-PDA method. Median blood alprazolam concentrations increased approximately 2 times compared with ante-mortem levels due to the redistribution during early post-mortem phase and then slowly decreased with a half-life of 60.7 h. The highest alprazolam tissue concentrations were found in fat and liver and the lowest levels were observed in lungs and brain. The median amount of alprazolam deposited in the lungs was relatively stable over the 24-h post-mortem period, while in heart, liver and kidney the deposited proportion of administered dose increased by 43-48% in comparison with ante-mortem values indicating continuous accumulation of alprazolam into these tissues. These results provide evidence needed for the interpretation of toxicological results in alprazolam-related fatalities and demonstrate modest alprazolam post-mortem redistribution.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21003457
003      
CZ-PrNML
005      
20210228090425.0
007      
ta
008      
210202s2020 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/23362936.2020.21 $2 doi
035    __
$a (PubMed)33270012
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hořínková, Jana $7 xx0241951 $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Post-mortem Redistribution of Alprazolam in Rats / $c J. Hořínková, P. Kozlík, T. Křížek, D. Michaličková, M. Šíma, O. Slanař
504    __
$a Literatura
520    9_
$a The post-mortem toxicological findings may be misinterpreted, if the drug undergoes substantial post-mortem redistribution. As alprazolam is one of the most frequently evaluated drug for legal/forensic reasons in drug-related fatalities, we studied possible changes in alprazolam distribution after death in a rat model. Rats were sacrificed 30 minutes after alprazolam administration. Blood and tissue samples from 8 animals per sampling time were collected at 0, 2, 6, and 24 h after death. The experimental samples were assayed for alprazolam using validated UHPLC-PDA method. Median blood alprazolam concentrations increased approximately 2 times compared with ante-mortem levels due to the redistribution during early post-mortem phase and then slowly decreased with a half-life of 60.7 h. The highest alprazolam tissue concentrations were found in fat and liver and the lowest levels were observed in lungs and brain. The median amount of alprazolam deposited in the lungs was relatively stable over the 24-h post-mortem period, while in heart, liver and kidney the deposited proportion of administered dose increased by 43-48% in comparison with ante-mortem values indicating continuous accumulation of alprazolam into these tissues. These results provide evidence needed for the interpretation of toxicological results in alprazolam-related fatalities and demonstrate modest alprazolam post-mortem redistribution.
650    12
$a alprazolam $x farmakokinetika $7 D000525
650    _2
$a zvířata $7 D000818
650    12
$a hypnotika a sedativa $x farmakokinetika $7 D006993
650    _2
$a posmrtné změny $7 D011180
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kozlík, Petr $7 xx0257220 $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Křížek, Tomáš, $d 1984- $7 mzk2007411142 $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Michaličková, Danica $7 xx0256887 $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Šíma, Martin $7 xx0222901 $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Slanař, Ondřej $7 xx0058262 $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
773    0_
$w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 121, č. 4 (2020), s. 244-253
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33270012 $y Pubmed
856    41
$u https://pmr.lf1.cuni.cz/media/pdf/pmr_2020121040244.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 7 $c 1071 $y p $z 0
990    __
$a 20210202 $b ABA008
991    __
$a 20210228090344 $b ABA008
999    __
$a ok $b bmc $g 1624807 $s 1123759
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 121 $c 4 $d 244-253 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
GRA    __
$a SVV 260523 $p Univerzita Karlova v Praze
GRA    __
$a UNCE/SCI/014 $p Univerzita Karlova v Praze
LZP    __
$b NLK118 $a Pubmed-20210202

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...